Jan 3, 2020 10:25 am EST EyeGate Announces Completion of $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Dec 2, 2019 6:55 am EST EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
Nov 7, 2019 6:55 am EST EyeGate Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update